1. Home
  2. Our Team
  3. Research Postgraduate Students
  4. Miss Boyuan WANG

Miss Boyuan WANG

Boyuan WANG

PhD Candidate, Department of Family medicine and Primary Care, The University of Hong Kong
Bachelor of Science in Nursing, Jilin University
Master of Public Health (Epidemiology & Biostatistics), The Chinese University of Hong Kong

Principle Supervisor: Dr. Eric Yuk Fai WAN
Co-supervisor: Professor Cindy L.K. LAM and Dr. Celine Sze Ling CHUI (School of Nursing)

email boyuanw@connect.hku.hk
Publications
  1. Wan, E. Y. F. †, Wang, B. Y. †, Lee, A. L. R., Zhou, J. Y., Chui, C. S. L., Lai, F. T. T., Li, X., Wong, C. K. H., Hung, I. F. N., Lau, C. S., Chan, E. W. Y. & Wong, I. C. K.. Comparative Effectiveness and Safety of BNT162b2 and CoronaVac in Hong Kong: A Target Trial Emulation. International Journal of Infectious Disease. 2024  (in press).
  2. Lai, F. T. T. †, Wang, B. Y. †, Wei, C.L., Chui, C. S. L., Li, X., Cheung, C.L., Wong, I. C. K., Chan, E. W. Y. & Wan, E. Y. F. Real-world effectiveness of molnupiravir and nirmatrelvir-ritonavir against mortality in hospitalised oldest-old people with high underlying morbidity burden: a territory-wide target trial emulation study. Age and Ageing. 2024. (in press).
  3. Wan, E. Y. F. †, Wang, B. †, Mathur, S. †, Chan, C. I. Y., Yan, V. K. C., Lai, F. T. T., Chui, C. S. L., Li, X., Wong, C. K. H., Li, P. H., Lau, C. S., Wong, I. C. K., & Chan, E. W. Y. (2023). Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during post-acute COVID-19 phase. Journal of Infection, 86(6), 622-625. https://doi.org/10.1016/j.jinf.2023.02.029
  4. Wan, E. Y. F†., Yan, V. K. C.†, Mok, A. H. Y.†, Wang, B. Y., Xu, W. C., Cheng, F. W. T., Lai, F. T. T., Chui, C. S. L., Li, X., Wong, C. K. H., Li, P. H., Cowling, B. J., Hung, I. F. N., Lau, C. S., Wong, I. C. K., & Chan, E. W. Y. (2023). Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 A Target Trial Emulation Study. Annals of Internal Medicine, 176(4), 505-+. https://doi.org/10.7326/m22-3057 
  5. Wan, E. Y. F.†, Mok, A. H. Y.†, Yan, V. K. C.†, Wang, B. Y., Zhang, R., Hong, S. N., Chui, C. S. L., Li, X., Wong, C. K. H., Lai, F. T. T., Tan, K. C. B., Lau, C. S., Wong, I. C. K., & Chan, E. W. Y. (2022). Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study. Journal of Infection, 85(5), E140-E144. https://doi.org/10.1016/j.jinf.2022.08.008
  6. Wan, E. Y. F., Mok, A. H. Y., Yan, V. K. C., Chan, C. I. Y., Wang, B. Y., Lai, F. T. T., Chui, C. S. L., Li, X., Wong, C. K. H., Lau, C. S., Wong, I. C. K., & Chan, E. W. Y. (2022). Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study. Journal of Travel Medicine, 29(8). https://doi.org/10.1093/jtm/taac119
  7. Wan, E. Y. F., Mathur, S., Zhang, R., Lam, A. H. Y., Wang, B., Yan, V. K. C., Chui, C. S. L., Li, X., Wong, C. K. H., Lai, F. T. T., Cheung, C. L., Chan, E. W. Y., Tan, K. C. B., & Wong, I. C. K. (2023). Long-term effects of coronavirus disease 2019 on diabetes complications and mortality in people with diabetes: Two cohorts in the UK and Hong Kong. Diabetes Obes Metab. https://doi.org/10.1111/dom.15279 
  8. Huang, J. J., Bai, Y. J., Ding, H. Y., Wang, B. Y., Ngai, C. H., Kwok, K. O., Wong, E. L. Y., Wong, M. C. S., & Yeoh, E. K. (2021). Acceptance of pneumococcal vaccination in older adults: A general population-based survey. Vaccine, 39(47), 6883-6893. https://doi.org/10.1016/j.vaccine.2021.10.024